Pipeline of Pancreatitis Market Reviewed for 7 Companies and 17 Drug Profiles in New Research Report

Mar 15, 2016, 08:30 ET from RnR Market Research

PUNE, India, March 15, 2016 /PRNewswire/ --

Market research report titled "Pancreatitis - Pipeline Review, H2 2015" enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Company Profiles discussed in this report includes Atox Bio Inc., CalciMedica, Inc., D-Pharm Ltd., Dynavax Technologies Corporation, Generon (Shanghai) Corporation Ltd., GlaxoSmithKline Plc and Pharming Group N.V. Complete report on H2 2015 pipeline review of Pancreatitis with 23 market data tables and 14 figures, spread across 72 pages is available at http://www.rnrmarketresearch.com/pancreatitis-pipeline-review-h2-2015-market-report.html .

Drugs Profiles discussed in this research includes AB-103, AEM-28-02, AEM-2814, C1 esterase inhibitor (human), CM-128, DPB-99, Drugs to Inhibit Kynurenine 3-Monooxygenase for Acute Pancreatitis, DV-1179, F-652, GSK-2795039, GSK-6288B, P-2pal18S, PZ-235, Recombinant Protein to Inhibit CXCL for Pancreatitis, Cardiovascular and Immunology, SBP-101, SBP-102 and SP-20201.

This report provides comprehensive information on the therapeutic development for Pancreatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pancreatitis and special features on late-stage and discontinued projects.

Order a copy of the pancreatitis pipeline review report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=447971 .

Scope of this report: The report provides a snapshot of the global therapeutic landscape of Pancreatitis. The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities and also key players involved in the therapeutics development for Pancreatitis and enlists all their major and minor projects summarizing all the dormant and discontinued pipeline projects. A review of the Pancreatitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources, pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages, detailed assessment of monotherapy and combination therapy pipeline projects, coverage of the Pancreatitis pipeline on the basis of target, MoA, route of administration and molecule type and latest news and deals relating related to pipeline products.

List of Tables 

Number of Products under Development for Pancreatitis, H2 2015

Number of Products under Development for Pancreatitis - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Comparative Analysis by Early Stage Development, H2 2015

Products under Development by Companies, H2 2015

Products under Investigation by Universities/Institutes, H2 2015

Assessment by Monotherapy Products, H2 2015

Number of Products by Stage and Target, H2 2015

Number of Products by Stage and Mechanism of Action, H2 2015

Number of Products by Stage and Route of Administration, H2 2015

Number of Products by Stage and Molecule Type, H2 2015

Pancreatitis Therapeutics - Recent Pipeline Updates, H2 2015

Pancreatitis - Dormant Projects, H2 2015

Pancreatitis - Discontinued Products, H2 2015

Another newly published market research report titled on Diphtheria - Pipeline Review, H2 2015 provides comprehensive information on the therapeutic development for Diphtheria, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diphtheria and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Diphtheria Pipeline market research report of 86 pages is available at http://www.rnrmarketresearch.com/diphtheria-pipeline-review-h2-2015-market-report.html .

Browse more reports on Therapeutics.

About Us:   

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.


Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@rnrmarketresearch.com

Connect with Us: 
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
Twitter: https://twitter.com/RnRMR
Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345


SOURCE RnR Market Research